The medical emergency team, evidence-based medicine and ethics

Medical Journal of Australia

Volumn 179, Issue 6, 2003, Pages 313-315

  Kerridge, Ross K ^a   Saul, W Peter ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYCLOOXYGENASE 2 INHIBITOR;

CHRONIC ARTHRITIS; DYING; EMERGENCY HEALTH SERVICE; EVIDENCE BASED MEDICINE; HEALTH CARE; HEALTH CARE COST; HEALTH CENTER; HOSPITAL; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; RESCUE PERSONNEL; REVIEW; SEPSIS; TREATMENT OUTCOME;

EID: 0141595107     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05556.x     Document Type: Review

References (22)

1. Lee A, Bishop G, Hillman K, Daffum K. The Medical Emergency Team. Anaesth Intensive Care 1995; 23: 183-186.
2. McQuillan P, Pilkington S, Allan A, et al. Confidential inquiry into quality of care before admission to intensive care. BMJ 1998; 316: 1853-1858.
3. Smith GB, Nolan J. Medical emergency teams and cardiac arrests in hospital. BMJ 2002; 324: 1215.
4. O'Dea J, Pepperman M, Bion J. Comprehensive critical care: A national strategic framework in all but name. Intensive Care Med 2003; 29: 341.
5. Bellomo R, Goldsmith D, Uchino S, et al. A prospective before-and-after trial of a medical emergency team. Med J Aust 2003; 179: 283-287.
6. Deane SA, Gaudry PL, Pearson I, et al. Implementation of a trauma team. Aust N Z J Surg 1989; 59: 373-378.
7. Buist M, Moore GE, Bernard SA, et al. Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital: Preliminary study. BMJ 2002; 324: 387-390.
8. Petticrew M. Why certain systematic reviews reach uncertain conclusions. BMJ 2003; 326: 756-758.
9. Sackett DL, Rosenberg WMC, Gray JAM, et al. Evidence based medicine: What it is and what it isn't. BMJ 1996; 312: 71-72.
10. Worrall J. What evidence in evidence-based medicine? Philos Sci 2002; 69: 316-331.
11. Bandolier. Evidence based thinking about health care. How systematic reviews can disappoint. Available at: www.jr2.ox.ac.uk/bandolier/band93/b93-6.html (accessed May 2003).
12. Rapid responses to: Buist M et al. BMJ 2002; 324: 387-390. Available at: bmj.com/cgi/eletters/324/7334/387 (accessed Jul 2003).
13. Ellis J, Mulligan I, Rowe J, Sackett DL. Inpatient general medicine is evidence-based. Lancet 1995; 346: 407-410.
14. Kerridge I, Lowe M, Henry D. Ethics and evidence based medicine. BMJ 1998; 316: 1151-1153.
15. Leeder SR, Rychetnik L. Ethics and evidence-based medicine. Med J Aust 2001; 175: 161-164.
16. Little M. "Better than numbers ⋯" A gentle critique of evidence-based medicine. Aust N Z J Surg 2003; 73: 177-182.
17. Woolridge M, quoted by Downey M. "Trust me I'm a doctor". Sydney Morning Herald 1997; 10 May: 1.
18. Manns BJ, Lee H, Doig CJ, et al. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002; 347: 993-1000.
19. Chalfin DB, Teres D, Rapoport J. A price for cost-effectiveness: Implications for recombinant human activated protein C (rhAPC). Crit Care Med 2003; 31: 306-308.
20. Eichacker PQ, Natanson C. Recombinant human activated protein C in sepsis: Inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials. Crit Care Med 2003; 31 (1 Suppl): S94-S96.
21. Spiegel BM, Targownik L, Dulai GS, Gralnek IM. The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis. Ann Intern Med 2003; 138: 795-806.
22. Marra CA, Esdaile JM, Sun H, Anis AH. The cost of COX inhibitors: How selective should we be? J Rheumatol 2000; 27: 2731-2733.